Immutep Limited (IMMP) Estados Financieros e Histórico

Immutep Limited (IMMP) — Precio $0.33 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Immutep Limited (IMMP): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Immutep Limited registró ingresos de $14.2M en el último ejercicio fiscal, con un CAGR de 5 años del 29.8%.

Márgenes de los últimos 12 meses: margen bruto 85.0%, margen operativo -6.0%, margen neto -5.4%.

Al precio actual de $0.33, IMMP presenta beneficios negativos (P/E no significativo) y un ROE del -126.06%. La capitalización bursátil es de $48M.

Cuenta de Resultados (10 años)

Año2017201820192020202120222023202420252026
Ingresos$4.2M$2.6M$139782$7.5M$3.9M$170369$3.5M$3.8M$5.0M$14.2M
Coste de Ventas$1.7M$10.0M$16.6M$22.5M$17.2M$2.1M$2.1M$41.5M$61.4M$2.4M
Beneficio Bruto$2.5M-$7.4M-$16.5M-$15.0M-$13.4M-$1.9M$1.4M-$37.7M-$56.4M$11.8M
I+D$7.5M$10.0M$16.6M$20.4M$17.2M$31.3M$28.8M$41.5M$61.4M$75.0M
Generales y Administrativos$4.3M$7.2M$6.1M$6.3M$6.3M$7.2M$14.1M$8.9M$8.6M$18.9M
Gastos Operativos$9.5M$14.8M$19.1M$22.6M$18.3M$32.5M$44.9M$50.4M$70.1M$93.9M
Beneficio Operativo-$9.4M-$11.7M-$20.4M-$16.0M-$31.7M-$33.9M-$77.7M-$88.1M-$126.4M-$82.0M
EBITDA-$8.4M-$10.4M-$16.5M-$11.4M-$17.8M-$31.9M-$39.6M-$44.5M-$62.9M-$79.6M
Gastos por Intereses000$10457$9825$92430$20401$305940$66411
Beneficio Antes de Impuestos-$10.1M-$12.7M-$18.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
Impuestos-$737387$1676-$2.1M$37$33$340000
Beneficio Neto-$9.4M-$12.7M-$16.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
BPA$-0.44$-0.48$-0.47$-0.33$-0.49$-0.37$-0.44$-0.36$-0.42$-0.53
BPA Diluido$-0.44$-0.48$-0.47$-0.33$-0.49$-0.37$-0.44$-0.36$-0.42$-0.53
Acciones en Circulación (Diluidas)$42.7M$42.7M$42.7M$40.7M$60.4M$86.2M$90.1M$120.1M$145.6M$147.2M

Cuenta de Resultados (Trimestral)

Año2024-Q42025-Q22025-Q42026-Q2
Ingresos$3.1M$1.9M$6.0M$10.6M
Beneficio Bruto-$22.2M-$34.2M-$40.6M$9.5M
Beneficio Operativo-$51.7M-$74.7M-$46.0M-$39.5M
EBITDA-$26.4M-$36.5M-$44.9M-$38.5M
Beneficio Neto-$22.4M-$39.1M-$44.9M-$34.9M
BPA$-0.15$-0.27$-0.30$-0.23
BPA Diluido$-0.15$-0.27$-0.30$-0.23

Balance (10 años)

Año2017201820192020202120222023202420252026
Caja y Equivalentes$12.2M$23.5M$16.6M$26.3M$60.1M$80.0M$123.4M$161.8M$67.4M$68.9M
Inversiones a Corto0000000$20.1M$62.3M0
Cuentas por Cobrar$2.2M$3.5M$5.2M$3.4M$6.1M$8.4M$8.0M$7.6M$7460$9.6M
Inventario$641998000-$5.7M00000
Activos Corrientes$15.9M$28.6M$23.5M$31.2M$68.4M$90.8M$135.0M$191.4M$149.1M$80.6M
Inmovilizado Material$24202$26449$52950$250571$309704$308080$468513$679723$569481$1.1M
Fondo de Comercio$109962$109962$109962$109962$109962$109962$109962$109962$109962$109967
Activos Intangibles$18.9M$18.2M$16.8M$15.1M$12.7M$10.4M$9.4M$8.1M$7.1M$1.4M
Activos Totales$35.0M$47.0M$40.5M$46.6M$82.0M$102.2M$147.4M$201.6M$157.0M$83.3M
Cuentas por Pagar$1.1M$1.6M$2.6M$1.6M$1.8M$2.9M$5.4M$3.8M$5.5M$5.9M
Deuda a Corto0000$208194000$1.1M$290165
Pasivos Corrientes$2.6M$3.9M$5.3M$3.4M$5.3M$6.4M$9.8M$10.5M$12.8M$14.2M
Deuda a Largo$5.8M$6.6M$7.6M$8.8M$2.5M$1.5M$835446$96076300
Pasivos Totales$8.4M$13.5M$16.2M$13.3M$8.8M$8.1M$11.0M$12.1M$13.3M$21.7M
Reservas-$231.8M-$244.6M-$262.2M-$275.7M-$274.6M-$302.3M-$339.9M-$382.6M-$444.1M-$520.8M
Patrimonio Neto$26.5M$33.5M$24.4M$33.3M$73.3M$94.1M$136.5M$189.5M$143.6M$61.5M
Deuda Total$5.8M$6.6M$7.6M$9.1M$2.8M$1.7M$1.2M$1.6M$1.6M$1.0M
Deuda Neta-$6.5M-$16.8M-$8.9M-$17.3M-$57.3M-$78.3M-$122.2M-$180.3M-$128.1M-$67.8M
Capital Circulante$13.3M$24.8M$18.2M$27.8M$63.1M$84.4M$125.2M$180.9M$136.3M$66.5M

Balance (Trimestral)

Año2024-Q42025-Q22025-Q42026-Q2
Caja y Equivalentes$73.9M$67.4M$72.7M$68.9M
Activos Totales$182.3M$157.0M$147.2M$83.3M
Pasivos Totales$9.9M$13.3M$48.3M$21.7M
Patrimonio Neto$172.5M$143.6M$98.9M$61.5M
Deuda Total$1.7M$1.6M$1.2M$1.0M

Flujo de Caja (10 años)

Año2017201820192020202120222023202420252026
Beneficio Neto-$9.4M-$12.7M-$18.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
Amortizaciones$1.7M$1.8M$1.9M$2.1M$2.1M$2.1M$2.1M$2.3M$2.4M$2.4M
Compensación en Acciones$862227$2.3M$1.6M$1.7M$1.7M$1.5M$2.0M$1.8M$1.2M0
Cambio en Capital Circulante-$2.2M-$252216-$345187$94163-$2.0M-$1.6M$764596$3.5M-$8.5M$16.2M
Flujo de Caja Operativo-$8.5M-$7.8M-$15.3M-$10.8M-$17.6M-$30.2M-$35.9M-$34.8M-$62.0M-$54.3M
Inversiones (CapEx)-$6644-$11893-$41434-$19348-$15601-$22914-$47000-$932369-$45769-$90895
Adquisiciones0000000000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$8.5M-$7.8M-$15.3M-$10.9M-$17.7M-$30.3M-$35.9M-$35.8M-$62.1M-$54.3M

Flujo de Caja (Trimestral)

Año2024-Q42025-Q22025-Q42026-Q2
Flujo de Caja Operativo-$28.5M-$33.5M-$28.1M-$29.1M
Inversiones (CapEx)-$11501-$34268-$90961-$6601
Flujo de Caja Libre-$28.6M-$33.5M-$28.2M-$29.2M
Dividendos Pagados0000
Compensación en Acciones0$1.2M00

Crecimiento y Márgenes (10 años)

Año2017201820192020202120222023202420252026
Crecimiento Ingresos (anual)-37.7%-94.7%+5255.8%-48.4%-95.6%+1957.7%+9.6%+31.3%+182.3%
Crecimiento Beneficio Neto (anual)-36.1%-27.7%+17.2%-122.0%-7.7%-23.9%-7.1%-43.8%-26.3%
Crecimiento BPA (anual)-9.1%+2.1%+29.8%-48.5%+24.5%-18.9%+18.2%-16.7%-26.2%
Cambio en Acciones (anual)+0.0%+0.0%-4.6%+48.4%+42.7%+4.4%+33.4%+21.2%+1.1%
Crecimiento FCF (anual)+8.5%-96.8%+29.2%-62.6%-71.3%-18.8%+0.5%-73.7%+12.5%
Margen Bruto59.7%-279.8%-11769.3%-200.2%-346.2%-1111.2%41.2%-981.4%-1117.6%83.0%
Margen Operativo-221.5%-444.5%-14606.5%-214.0%-820.0%-19920.0%-2216.0%-2293.3%-2506.5%-576.2%
Margen EBITDA-199.1%-394.5%-11778.9%-152.0%-460.0%-18708.9%-1128.8%-1159.4%-1246.6%-559.2%
Margen Neto-221.9%-484.6%-11640.0%-179.9%-774.1%-18906.5%-1138.0%-1111.9%-1218.0%-544.8%
Margen FCF-201.7%-296.1%-10965.5%-145.0%-457.1%-17757.1%-1024.9%-930.6%-1231.1%-381.7%
Tasa Impositiva Efectiva7.3%-0.0%11.3%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Datos por Acción (10 años)

Año2017201820192020202120222023202420252026
FCF por Acción$-0.20$-0.18$-0.36$-0.27$-0.29$-0.35$-0.40$-0.30$-0.43$-0.37
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$42.7M$42.7M$42.7M$40.7M$60.4M$86.2M$90.1M$120.0M$145.6M$147.2M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-126.06%
Rentabilidad sobre capital invertido-118.22%
Rentabilidad sobre activos-93.15%
Margen bruto84.97%
Margen operativo-597.44%
Margen neto-544.79%

Salud financiera

Deuda / Patrimonio0.02
Ratio corriente5.69
Piotroski F-Score2
Altman Z-Score10.76

Ratios Clave (10 años)

Año2017201820192020202120222023202420252026
P/E-21.15-22.40-17.54-15.75-10.42-7.86-7.15-8.48-5.90-1.13
P/VC15.0413.6414.406.384.252.702.091.912.531.44
P/V94.55173.762511.6528.3780.701488.2381.3594.2471.926.23
Margen Bruto59.7%-279.8%-11769.3%-200.2%-346.2%-1111.2%41.2%-981.4%-1117.6%83.0%
Margen Operativo-221.5%-444.5%-14606.5%-214.0%-820.0%-19920.0%-2216.0%-2293.3%-2506.5%-576.2%
Margen Neto-221.9%-484.6%-11640.0%-179.9%-774.1%-18906.5%-1138.0%-1111.9%-1218.0%-544.8%

Empresas relacionadas: ACHV · ALLO · CABA · CADL · CAPR · EDIT · MREO

Explorar sector: Healthcare · Biotechnology

Más secciones de IMMP: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones